Using the METABRIC dataset (Curtis et al., 2012), we showed that increased FOXM1 expression correlates with poorer survival in PIK3CA mutant breast cancer patients and that survival is decreased in ER+ breast cancer patients with FOXM1 copy number gain. Here, PIK3CA is linked to breast carcinoma.